These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31709528)

  • 21. Treg programming and therapeutic reprogramming in cancer.
    Moreno Ayala MA; Li Z; DuPage M
    Immunology; 2019 Jul; 157(3):198-209. PubMed ID: 30866047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
    Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
    Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
    Colbeck EJ; Hindley JP; Smart K; Jones E; Bloom A; Bridgeman H; McPherson RC; Turner DG; Ladell K; Price DA; O'Connor RA; Anderton SM; Godkin AJ; Gallimore AM
    Oncotarget; 2015 Sep; 6(28):24649-59. PubMed ID: 26433463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.
    Lu Y; Li Y; Liu Q; Tian N; Du P; Zhu F; Han Y; Liu X; Liu X; Peng X; Wang X; Wu Y; Tong L; Li Y; Zhu Y; Wu L; Zhang P; Xu Y; Chen H; Li B; Tong X
    Gastroenterology; 2021 Aug; 161(2):575-591.e16. PubMed ID: 33901495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
    Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
    Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.
    Santegoets SJ; Duurland CL; Jordanova ES; van Ham JJ; Ehsan I; van Egmond SL; Welters MJP; van der Burg SH
    J Immunother Cancer; 2019 Jan; 7(1):14. PubMed ID: 30658697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma.
    Toker A; Nguyen LT; Stone SC; Yang SYC; Katz SR; Shaw PA; Clarke BA; Ghazarian D; Al-Habeeb A; Easson A; Leong WL; McCready DR; Reedijk M; Guidos CJ; Pugh TJ; Bernardini MQ; Ohashi PS
    Clin Cancer Res; 2018 Nov; 24(22):5685-5696. PubMed ID: 30065096
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.
    Karim R; Jordanova ES; Piersma SJ; Kenter GG; Chen L; Boer JM; Melief CJ; van der Burg SH
    Clin Cancer Res; 2009 Oct; 15(20):6341-7. PubMed ID: 19825956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment.
    Chevalier N; Mueller M; Mougiakakos D; Ihorst G; Marks R; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016 Sep; 57(9):2150-60. PubMed ID: 26757600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis.
    McEachern E; Carroll AM; Fribourg M; Schiano TD; Hartzell S; Bin S; Cravedi P; Levitsky J
    J Autoimmun; 2021 May; 119():102629. PubMed ID: 33721837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic profiles of regulatory T cells in the tumour microenvironment.
    Rao D; Verburg F; Renner K; Peeper DS; Lacroix R; Blank CU
    Cancer Immunol Immunother; 2021 Sep; 70(9):2417-2427. PubMed ID: 33576875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CD39
    Magid-Bernstein JR; Rohowsky-Kochan CM
    J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T Cells Suppress Natural Killer Cell Immunity in Patients With Human Cervical Carcinoma.
    Chang WC; Li CH; Chu LH; Huang PS; Sheu BC; Huang SC
    Int J Gynecol Cancer; 2016 Jan; 26(1):156-62. PubMed ID: 26512789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
    Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
    Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression.
    Bu M; Shen Y; Seeger WL; An S; Qi R; Sanderson JA; Cai Y
    Tumour Biol; 2016 Mar; 37(3):3949-56. PubMed ID: 26482613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.